Loading...
Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer
BACKGROUND: Survival from gastric cancer remains poor, particularly in Western populations. Previous pre-clinical and subgroup analyses of clinical trials have suggested differing benefits from fluoropyrimidine-based chemotherapeutics for diffuse and intestinal gastric cancer. This analysis examines...
Saved in:
| Published in: | PLoS One |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Public Library of Science
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5602536/ https://ncbi.nlm.nih.gov/pubmed/28922362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0183891 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|